TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | ¥55 | ¥45 | ¥42 | ¥42 |
| - Cash | ¥9 | ¥9 | ¥1 | ¥6 |
| + Debt | ¥14 | ¥10 | ¥6 | ¥5 |
| Enterprise Value | ¥60 | ¥45 | ¥47 | ¥40 |
| Revenue | ¥19 | ¥18 | ¥16 | ¥17 |
| % Growth | 1% | 17.6% | -10.2% | – |
| Gross Profit | ¥12 | ¥12 | ¥9 | ¥14 |
| % Margin | 66.2% | 67.8% | 56.1% | 81.8% |
| EBITDA | ¥9 | ¥9 | ¥5 | ¥9 |
| % Margin | 48.4% | 46.9% | 33.9% | 49% |
| Net Income | ¥6 | ¥6 | ¥3 | ¥4 |
| % Margin | 33.9% | 31.3% | 19.4% | 25.7% |
| EPS Diluted | 58.9 | 57.74 | 30.35 | 44.81 |
| % Growth | 2% | 90.2% | -32.3% | – |
| Operating Cash Flow | ¥7 | ¥10 | -¥3 | ¥11 |
| Capital Expenditures | -¥5 | -¥4 | -¥1 | -¥2 |
| Free Cash Flow | ¥2 | ¥6 | -¥4 | ¥8 |